Your browser doesn't support javascript.
loading
fdrci: FDR confidence interval selection and adjustment for large-scale hypothesis testing.
Millstein, Joshua; Battaglin, Francesca; Arai, Hiroyuki; Zhang, Wu; Jayachandran, Priya; Soni, Shivani; Parikh, Aparna R; Mancao, Christoph; Lenz, Heinz-Josef.
Afiliação
  • Millstein J; Department of Population and Public Health Sciences, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
  • Battaglin F; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
  • Arai H; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
  • Zhang W; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
  • Jayachandran P; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
  • Soni S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
  • Parikh AR; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Mancao C; Biomarker Development, Innovent Biologics, Suzhou 215123, China.
  • Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
Bioinform Adv ; 2(1): vbac047, 2022.
Article em En | MEDLINE | ID: mdl-35747247
ABSTRACT
Motivation Approaches that control error by applying a priori fixed discovery thresholds such as 0.05 limit the ability of investigators to identify and publish weak effects even when evidence suggests that such effects exist. However, current false discovery rate (FDR) estimation methods lack a principled approach for post hoc identification of discovery thresholds other than 0.05.

Results:

We describe a flexible approach that hinges on the precision of a permutation-based FDR estimator. A series of discovery thresholds are proposed, and an FDR confidence interval selection and adjustment technique is used to identify intervals that do not cover one, implying that some discoveries are expected to be true. We report an application to a transcriptome-wide association study of the MAVERICC clinical trial involving patients with metastatic colorectal cancer. Several genes are identified whose predicted expression is associated with progression-free or overall survival. Availability and implementation Software is provided via the CRAN repository (https//cran.r-project.org/web/packages/fdrci/index.html). Supplementary information Supplementary data are available at Bioinformatics Advances online.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Bioinform Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Bioinform Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos